Journal of Substance Abuse Treatment
Volume 37, Issue 4 , Pages 353-361 , December 2009

Health-related quality of life trajectories of methamphetamine-dependent individuals as a function of treatment completion and continued care over a 1-year period

  • Rachel Gonzales, Ph.D.

      Affiliations

    • Integrated Substance Abuse Programs, University of California, Los Angeles, CA 90025, USA
    • Corresponding Author InformationCorresponding author. Rachel Gonzales, Ph.D., 1640 S. Sepulveda Blvd, Suite 200, Los Angeles, CA 90025, USA. Tel.: +1 310 267 5554; fax: +1 310 312 0538.
    • ,
  • Alfonso Ang, Ph.D.

      Affiliations

    • David Geffen School of Medicine, University of California, Los Angeles, CA 90024, USA
    • ,
  • Patricia Marinelli-Casey, Ph.D.

      Affiliations

    • Integrated Substance Abuse Programs, University of California, Los Angeles, CA 90025, USA
    • ,
  • Deborah C. Glik, Sc.D.

      Affiliations

    • School of Public Health, University of California, Los Angeles, CA 90024, USA
    • ,
  • Martin Y. Iguchi, Ph.D.

      Affiliations

    • School of Public Health, University of California, Los Angeles, CA 90024, USA
    • ,
  • Richard A. Rawson, Ph.D.

      Affiliations

    • Integrated Substance Abuse Programs, University of California, Los Angeles, CA 90025, USA
    • ,
  • Methamphetamine Treatment Project Corporate Authors

      Affiliations

    • Acknowledgments detail Corporate Author list.

Received 7 November 2008 ,Revised 26 March 2009 ,Accepted 3 April 2009.

References 

  1. Anglin MD, Hser Y-I, Grella CE. Drug addiction and treatment careers among clients in the Drug Abuse Treatment Outcome Study (DATOS). Psychology of Addictive Behaviors. 1997;11:308–323
  2. Booth BM, Blow FC, Cook L. Persistence of impaired functioning and psychological distress after hospitalization for men with co-occurring psychiatric and substance use disorders. Journal of General Internal Medicine. 2001;16:57–65
  3. Brecht ML, Greenwell L, Anglin MD. Methamphetamine treatment: Trends and predictors of retention and completion in a large state treatment system (1992–2002). Journal of Substance Abuse Treatment. 2005;29:295–306
  4. Cacciola JS, Camilleri AC, Carise D, Rikoon SH, McKay JR, McLellan AT, et al. Extending residential care through telephone counseling: Initial results from the Betty Ford Center Focused Continuing Care protocol. Addictive Behaviors. 2008;33:1208–1216
  5. Evans E, Longshore D. Evaluation of the substance abuse and crime prevention act: Treatment clients and program types during the first year of implementation. Journal of Psychoactive Drugs. 2004;(Suppl 2):165–174
  6. Farabee D, Prendergast M, Cartier L. Methamphetamine use and HIV risk among substance-abusing offenders in California. Journal of Psychoactive Drugs. 2002;34:295–300
  7. Freeman K. Health and well-being outcomes for drug-dependent offenders on the NSW Drug Court programme. Drug & Alcohol Review. 2003;22:409–416
  8. Galloway GP, Marinelli-Casey P, Stalcup J, Lord RH, Christian D, Cohen J, et al. Treatment-as-usual in the Methamphetamine Treatment Project. Journal of Psychoactive Drugs. 2000;32:165–175
  9. Garg N, Yates WR, Jones R, Zhou M, Williams S. Effect of gender, treatment site and psychiatric comorbidity on quality of life outcome in substance dependence. American Journal on Addictions. 1999;8:44–54
  10. Glasner-Edwards. S., Marinelli-Casey. P., Hillhouse. M., Ang. A., Mooney, LJ., Rawson, R., et al. (In press). Depression among methamphetamine users: Association with outcomes from the Methamphetamine Treatment Project at 3-year follow-up. American Journal of Psychiatry.
  11. Gonzales R, Marinelli-Casey P, Hillhouse M, Hunter J, Rawson R, Mooney L, et al. Hepatitis A and B infection among methamphetamine-dependent users. Journal of Substance Abuse Treatment. 2008;35:351–352
  12. Greenfield SF, Brooks AJ, Gordon SM, Green CA, Kropp F, McHugh RK, et al. Substance abuse treatment entry, retention and outcome in women: A review of the literature. Drug and Alcohol Dependence. 2007;86:1–21
  13. Greenwell L, Brecht ML. Self-reported health status among treated methamphetamine users. American Journal of Drug and Alcohol Abuse. 2003;29:75–104
  14. Grella CE, Joshi V. Gender differences in drug treatment careers among clients in the national Drug Abuse Treatment Outcome Study. American Journal of Drug & Alcohol Abuse. 1999;25:385–406
  15. Griffin KW, Rabkin JG, Remein RH, Williams JB. Disease severity, physical limitations, and depression in HIV-infected men. Journal of Psychosomatic Research. 1998;44:219–227
  16. Gual A, Balcells M, Torres M, Madrigal M, Diez T, Serrano L. Sertraline for the prevention of relapse in detoxicated alcohol dependent patients with a comorbid depressive disorder: A randomized controlled trial. Alcohol & Alcoholism. 2003;38:619–625
  17. Hser Y-I, Longshore D, Anglin A. The life course perspective on drug use: A conceptual framework for understanding drug use trajectories. Evaluation Review. 2009;31:515–547
  18. Huber A, Lord RH, Gulati V, Marinelli-Casey P, Rawson RA, Ling W. The CSAT Methamphetamine Treatment Project: Research design accommodations for “real world” application. Journal of Psychoactive Drugs. 2000;32:149–156
  19. Iguchi MY, London JA, Forge NG, Hickman L, Fain T, Riehman K. Elements of well-being affected by criminalizing the drug user. Public Health Reports. 2002;117(Suppl 1):S146–S150
  20. Kiritze-Topor P, Huas D, Rosenzweig C, Comte S, Paille F, Lehert P. A pragmatic trial of acamprosate in the treatment of alcohol dependence in primary care. Alcohol & Alcoholism. 2004;39:520–527
  21. Kraemer KL, Maisto SA, Conigliaro J, McNeil M, Gordon AJ, Kelley ME. Decreased alcohol consumption in outpatient drinkers is associated with improved quality of life and fewer alcohol-related consequences. Journal of General and Internal Medicine. 2002;17:382–386
  22. McKay JR. Is there a case for extended interventions for alcohol and drug use disorders?. Addiction. 2005;100:1594–1610
  23. McKay J, Weiss R. A review of temporal effects and outcome predictors in substance abuse treatment studies with long-term follow-ups. Evaluation Review. 2001;25:113–161
  24. McKetin R, Mattick RP. Attention and memory in illicit amphetamine users: Comparison with non–drug-using controls. Drug and Alcohol Dependence. 1998;50:181–184
  25. McLellan AT, Kushner H, Metzger D, Peters R, Smith I, Grissom G, et al. The fifth edition of the Addiction Severity Index. Journal of Substance Abuse Treatment. 1992;9:199–213
  26. McLellan AT, Lewis DC, O'Brien CP, Kleber HD. Drug dependence, a chronic medical illness: Implications for treatment, insurance, and outcomes evaluation. Journal of the American Medical Association. 2000;284:1689–1695
  27. McLellan AT, McKay JR, Forman R, Cacciola J, Kemp J. Reconsidering the evaluation of addiction treatment: From retrospective follow-up to concurrent recovery monitoring. Addiction. 2005;100:447–458
  28. Mendlowicz MV, Stein MB. Quality of life in individuals with anxiety disorders. American Journal of Psychiatry. 2000;157:669–682
  29. Meredith CW, Jaffe C, Ang-Lee K, Saxon AJ. Implications of chronic methamphetamine use: A literature review. Harvard Review of Psychiatry. 2005;13:141–154
  30. Morgan TJ, Morgenstern J, Blanchard KA, Labouvie E, Bux DA. Health-related quality of life for adults participating in outpatient substance abuse treatment. American Journal on Addictions. 2003;12:198–210
  31. Neale J. Measuring the health of Scottish drug users. Health and Social Care in the Community. 2004;12:202–211
  32. Obert JL, McCann MJ, Brethen P, Marinelli-Casey P, Rawson RA. The Matrix Model of outpatient substance abuse treatment: History and description. Journal of Psychoactive Drugs. 2000;32:157–165
  33. Perneger TV, Giner F, del Rio M, Mino A. Randomized trial of heroin maintenance programme for addicts who fail conventional drug treatments. British Journal of Medicine. 1998;317:13–18
  34. Prendergast M, Podus D, Chang E. Program factors and treatment outcomes in drug dependence treatment: An examination using meta-analysis. Substance Use and Misuse. 2000;35:1931–1965
  35. Puigdollers E, Domingo-Salvany A, Brugal MT, Torrens M, Alvaros J, Castillo C, et al. Characteristics of heroin addicts entering methadone maintenance treatment: Quality of life and gender. Substance Use & Misuse. 2004;39:1353–1368
  36. Rawson R, Shoptaw S, Obert J, McCann M, Hasson A, Marinelli-Casey P, et al. An intensive outpatient approach for cocaine abuse treatment: The Matrix model. Journal of Substance Abuse Treatment. 1995;12:117–127
  37. Rawson RA, Maranelli-Casey P, Anglin MD, Dickow A, Frazier Y, Gallagher C, et al. Methamphetamine Treatment Project Corporate Authors. A multi-site comparison of psychosocial approaches for the treatment of methamphetamine dependence. Addiction. 2004;99:708–717
  38. Rawson RA, Gonzales RG, Ling W. Methamphetamine abuse and dependence: An update. Directions in Psychiatry. 2006;26:221–236
  39. Rawson RA, Gonzales R, Pearce V, Ang A, Marinelli-Casey P, Brummer J, et al. Methamphetamine dependence and human immunodeficiency virus risk behavior. Journal of Substance Abuse Treatment. 2008;35:279–284
  40. Richter D, Eikelmann B, Berger K. Use of the SF-36 in the evaluation of a drug detoxification program. Quality of Life Research. 2004;13:907–914
  41. Semple SJ, Zians J, Grant I, Patterson TL. Impulsivity and methamphetamine use. Journal of Substance Abuse Treatment. 2005;29:85–93
  42. Substance Abuse , Mental Health Services Administration, Office of Applied Studies . Results from the 2007 National Survey on Drug Use and Health: National Findings (NSDUH Series H-34, DHHS Publication No. SMA 08-4343). Rockville, MD: Author; 2008;
  43. Torrens M, San L, Martinez A, Castilo C, Domingo-Salvany A, Alonso J. Use of the Nottingham Health Profile for measuring the health status of patients in methadone maintenance treatment. Addiction. 1997;92:707–716
  44. Ware JE, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36). I. Conceptual framework and item selection. Medical Care. 1992;30:473–483
  45. Ware JE, Snow KK, Kolinski M, Gandeck B. SF-36 health survey manual and interpretation guide. Boston, MA: The Health Institute, New England Medical Centre; 1993;
  46. Ware JE. SF-36 physical and mental health summary scales: A user's manual. Boston, MA: The Health Institute, New England Medical Center; 1994;
  47. Wells KB, Stewart A, Hayes RD, Burnam MA, Rogers W, Daniels M, et al. The functioning and well being of depressed patients: Results from the medical outcomes study. Journal of American Medical Association. 1989;262:914–919
  48. World Health Organization Quality of Life assessment . Position paper from the World Health Organization. Social Science & Medicine. 1995;41:1403–1409
  49. Zweben JE, Cohen JB, Christian D, Galloway GP, Salinard M, Parent D, et al. Psychiatric symptoms in methamphetamine users. American Journal on Addictions. 2004;13:181–190

PII: S0740-5472(09)00040-3

doi: 10.1016/j.jsat.2009.04.001

Journal of Substance Abuse Treatment
Volume 37, Issue 4 , Pages 353-361 , December 2009

Article Tools

* Image Usage & Resolution